ImmuneWatch supports academics, clinical-stage biotech and pharma companies by using machine learning to identify T-cell receptor targets and analyse immune responses, helping improve (cancer) vaccines and immunotherapies.
| Website | https://www.immunewatch.com |
| Employees | 7 (4 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Immunotherapy Research, Pharmaceutical Research, Academic Research Collaboration, Target Identification, Clinical Trial Support, Drug Development Support, Vaccine Development, Precision Medicine, Immuno-Oncology, Data Analysis, Bioinformatics, Therapeutics Research, Healthcare Technology |
| Competitors | Celltrion Inc, Roche, Thermo Fisher Scientific, Bristol Myers Squibb, Amgen, AstraZeneca, AbbVie, Pfizer, Merck & Co., Inc., Johnson & Johnson +43 more (view full list) |
Looking for a particular ImmuneWatch employee's phone or email?
Sander Wuyts is the CEO and Co-founder of ImmuneWatch.
4 people are employed at ImmuneWatch.
ImmuneWatch is based in Antwerp, Flanders.